Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
- PMID: 23443445
- DOI: 10.1001/jama.2013.879
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
Abstract
The CONSORT (Consolidated Standards of Reporting Trials) Statement aims to improve the reporting of randomized controlled trials (RCTs); however, it lacks guidance on the reporting of patient-reported outcomes (PROs), which are often inadequately reported in trials, thus limiting the value of these data. In this article, we describe the development of the CONSORT PRO extension based on the methodological framework for guideline development proposed by the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network. Five CONSORT PRO checklist items are recommended for RCTs in which PROs are primary or important secondary end points. These recommendations urge that the PROs be identified as a primary or secondary outcome in the abstract, that a description of the hypothesis of the PROs and relevant domains be provided (ie, if a multidimensional PRO tool has been used), that evidence of the PRO instrument's validity and reliability be provided or cited, that the statistical approaches for dealing with missing data be explicitly stated, and that PRO-specific limitations of study findings and generalizability of results to other populations and clinical practice be discussed. Examples and an updated CONSORT flow diagram with PRO items are provided. It is recommended that the CONSORT PRO guidance supplement the standard CONSORT guidelines for reporting RCTs with PROs as primary or secondary outcomes. Improved reporting of PRO data should facilitate robust interpretation of the results from RCTs and inform patient care.
Comment in
-
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.Value Health. 2013 Jun;16(4):455-6. doi: 10.1016/j.jval.2013.04.001. Value Health. 2013. PMID: 23796277 No abstract available.
Similar articles
-
Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.Trials. 2018 Jul 31;19(1):407. doi: 10.1186/s13063-018-2733-1. Trials. 2018. PMID: 30060754 Free PMC article.
-
Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.Cancer. 2015 Sep 15;121(18):3335-42. doi: 10.1002/cncr.29489. Epub 2015 Jun 16. Cancer. 2015. PMID: 26079197 Free PMC article.
-
CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.Trials. 2018 Jul 31;19(1):406. doi: 10.1186/s13063-018-2735-z. Trials. 2018. PMID: 30060763 Free PMC article.
-
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.JAMA. 2012 Dec 26;308(24):2594-604. doi: 10.1001/jama.2012.87802. JAMA. 2012. PMID: 23268518
-
Quality of patient-reported outcome reporting according to the CONSORT statement in randomized controlled trials with glioblastoma patients.Neurooncol Pract. 2020 Nov 11;8(2):148-159. doi: 10.1093/nop/npaa074. eCollection 2021 Apr. Neurooncol Pract. 2020. PMID: 33898048 Free PMC article.
Cited by
-
Patient Acceptable Symptom State Thresholds for IKDC-SKF and KOOS at the 10-Year Follow-up After Anterior Cruciate Ligament Injury: A Study From the Delaware-Oslo ACL Cohort.Orthop J Sports Med. 2024 May 29;12(5):23259671241250025. doi: 10.1177/23259671241250025. eCollection 2024 May. Orthop J Sports Med. 2024. PMID: 38827138 Free PMC article.
-
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS).Hemasphere. 2024 May 21;8(5):e69. doi: 10.1002/hem3.69. eCollection 2024 May. Hemasphere. 2024. PMID: 38774655 Free PMC article. Review.
-
Application of online to offline teaching mode in the training of non-anesthesiology residents in the department of anesthesiology: a randomized, controlled trial.Front Med (Lausanne). 2024 Apr 29;11:1329538. doi: 10.3389/fmed.2024.1329538. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38741763 Free PMC article.
-
Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study.J Med Internet Res. 2024 May 8;26:e45719. doi: 10.2196/45719. J Med Internet Res. 2024. PMID: 38718388 Free PMC article.
-
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.J Patient Rep Outcomes. 2024 May 2;8(1):48. doi: 10.1186/s41687-024-00719-7. J Patient Rep Outcomes. 2024. PMID: 38695992 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous